GEN Exclusives

More »
New Products

Related to NHGRI Fortifies Third-Generation Sequencing Development with $18M

    • Stabilized Pepsin
    • SciGene
    • CytoZyme™ stabilized pepsin is an advanced formulation for pretreating tissue samples in nucleic acid probe-based cytogenetic assays including FISH. CytoZyme is a ready-to-use solution of purified pepsin that can be stored in the refrigerator witho
    • RNA Detection Probes
    • EMD Millipore
    • SmartFlare™ probes employ inert nanoparticle technology to detect native RNA. The probes are added to cell cultures and incubated overnight. RNA detection is then performed using any fluorescent detection platform. Once an experiment is complete, t
    • Library Quantification Kit
    • Bio-Rad
    • Used with the QX100™ Droplet Digital™ PCR system, the ddPCR™ library quantification kit lets researchers directly measure amplifiable library concentrations. The TruSeq sample preparation method is the technique behind Illumina’s MiSeq and HiSeq ne
    • Sequencing System
    • Pacific Biosciences
    • The PacBio RS II allows scientists to generate finished genome assemblies, reveal and understand epigenomes, and characterize genomic variation. Based on the SMRT sequencing technology, the RS II can generate average read lengths of 5,000 base pair
    • Kits for Analyzing Modified Cytosines
    • Cambridge Epigenetix
    • TrueMethyl™ kits provide quantitative, accurate and repeatable single-base resolution sequencing of the modified bases hydroxymethylcytosine (5-hmC) and methylcytosine (5-mC) in genomic DNA. This capability is attributable to the kits’ utiliza
  • Page 1 of 1 (5 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?